Ferlay J, et al. Cancer statistics for the year 2020: An overview. Int J Cancer. 2021;149(4):778–89.
Borras JM, et al. How many new cancer patients in Europe will require radiotherapy by 2025? An ESTRO-HERO analysis. Radiother Oncol. 2016;119(1):5–11.
Jeggo P, Löbrich M. Radiation-induced DNA damage responses. Radiat Prot Dosimetry. 2006;122(1–4):124–7.
PubMed Article CAS Google Scholar
Lomax ME, Folkes LK, O’Neill P. Biological consequences of radiation-induced DNA damage: relevance to radiotherapy. Clin Oncol. 2013;25(10):578–85.
Saitoh T, Oda T. DNA damage response in multiple myeloma: the role of the tumor microenvironment. Cancers. 2021;13(3):504.
CAS PubMed PubMed Central Article Google Scholar
Asur R, et al. High dose bystander effects in spatially fractionated radiation therapy. Cancer Lett. 2015;356(1):52–7.
CAS PubMed Article Google Scholar
D’Andrea MA, Reddy GK. Systemic immunostimulatory effects of radiation therapy improves the outcomes of patients with advanced NSCLC receiving immunotherapy. Am J Clin Oncol. 2020;43(3):218–28.
PubMed Article CAS Google Scholar
Daly ME, Monjazeb AM, Kelly K. Clinical trials integrating immunotherapy and radiation for non–small-cell lung cancer. J Thorac Oncol. 2015;10(12):1685–93.
CAS PubMed Article Google Scholar
Diehn M, et al. Association of reactive oxygen species levels and radioresistance in cancer stem cells. Nature. 2009;458(7239):780–3.
CAS PubMed PubMed Central Article Google Scholar
Nikitaki Z, et al. Systemic mechanisms and effects of ionizing radiation: A new ‘old’ paradigm of how the bystanders and distant can become the players. Semin Cancer Biol. 2016;37–38:77–95.
PubMed Article CAS Google Scholar
Kadhim MA, Hill MA. Non-targeted effects of radiation exposure: recent advances and implications: Figure 1. Radiat Prot Dosimetry. 2015;166(1–4):118–24.
CAS PubMed Article Google Scholar
Wang Y. Advances in hypofractionated irradiation-induced immunosuppression of tumor microenvironment. Front Immunol. 2021;11:612072.
PubMed PubMed Central Article CAS Google Scholar
Demaria S, et al. Ionizing radiation inhibition of distant untreated tumors (abscopal effect) is immune mediated. Int J Radiat Oncol Biol Phys. 2004;58(3):862–70.
Rodriguez-Ruiz ME, et al. Abscopal effects of radiotherapy are enhanced by combined immunostimulatory mAbs and are dependent on CD8 T cells and crosspriming. Can Res. 2016;76(20):5994–6005.
Golden EB, et al. Local radiotherapy and granulocyte-macrophage colony-stimulating factor to generate abscopal responses in patients with metastatic solid tumours: a proof-of-principle trial. Lancet Oncol. 2015;16(7):795–803.
CAS PubMed Article Google Scholar
Zhu M, et al. Immunogenic cell death induction by ionizing radiation. Front Immunol. 2021;12:705361.
CAS PubMed PubMed Central Article Google Scholar
Golden EB, Apetoh L. Radiotherapy and immunogenic cell death. Semin Radiat Oncol. 2015;25(1):11–7.
Walle T, et al. Radiation effects on antitumor immune responses: current perspectives and challenges. Ther Adv Med Oncol. 2018;10:175883401774257.
Johnson CB, Jagsi R. The promise of the abscopal effect and the future of trials combining immunotherapy and radiation therapy. Int J Radiat Oncol Biol Phys. 2016;95(4):1254–6.
Frey B, et al. Antitumor immune responses induced by ionizing irradiation and further immune stimulation. Cancer Immunol Immunother. 2014;63(1):29–36.
CAS PubMed Article Google Scholar
•• Hader M, et al. Immune biological rationales for the design of combined radio- and immunotherapies. Cancer Immunol Immunother. 2020;69(2):293–306. Key aspects are reviewed that suggest the use of hyperthermia treatment as a adjuvant treatment for radiotherapy and immunotherapies based on several direct and indirect effects of these treatments on the immune system.
Ngwa W, et al. Using immunotherapy to boost the abscopal effect. Nat Rev Cancer. 2018;18(5):313–22.
CAS PubMed PubMed Central Article Google Scholar
Jarosz-Biej M, et al. Tumor microenvironment as a “game changer” in cancer radiotherapy. Int J Mol Sci. 2019;20(13):3212.
CAS PubMed Central Article Google Scholar
Colton M, et al. Reprogramming the tumour microenvironment by radiotherapy: implications for radiotherapy and immunotherapy combinations. Radiat Oncol. 2020;15(1):254.
PubMed PubMed Central Article Google Scholar
Dunn GP, Old LJ, Schreiber RD. The three Es of cancer immunoediting. Annu Rev Immunol. 2004;22(1):329–60.
CAS PubMed Article Google Scholar
Giraldo NA, et al. The clinical role of the TME in solid cancer. Br J Cancer. 2018;120(1):45–53.
PubMed PubMed Central Article Google Scholar
Yu YR, Ho PC. Sculpting tumor microenvironment with immune system: from immunometabolism to immunoediting. Clin Exp Immunol. 2019;197(2):153–60.
CAS PubMed Article Google Scholar
Dyck L, Mills KHG. Immune checkpoints and their inhibition in cancer and infectious diseases. Eur J Immunol. 2017;47(5):765–79.
CAS PubMed Article Google Scholar
Krysko O, et al. Necroptotic cell death in anti-cancer therapy. Immunol Rev. 2017;280(1):207–19.
CAS PubMed Article Google Scholar
• Rückert M, et al. Radiotherapy and the immune system: more than just immune suppression. Stem Cells. 2021;39(9):1155–65. In this review, both the stimulating and suppressing effects of radiotherapy are explained in detail, and the use of radiotherapy in combination with distintc immune therapies is discussed.
Keam S, et al. Enhancing the efficacy of immunotherapy using radiotherapy. Clin Transl Immunol. 2020;9(9):e1169.
Apetoh L, et al. Toll-like receptor 4–dependent contribution of the immune system to anticancer chemotherapy and radiotherapy. Nat Med. 2007;13(9):1050–9.
CAS PubMed Article Google Scholar
Burnette BC, et al. The efficacy of radiotherapy relies upon induction of type I interferon–dependent innate and adaptive immunity. Can Res. 2011;71(7):2488–96.
Galluzzi L, et al. Immunogenic cell death in cancer and infectious disease. Nat Rev Immunol. 2016;17(2):97–111.
PubMed Article CAS Google Scholar
Schmid TE, Multhoff G. Radiation-induced stress proteins - the role of heat shock proteins (HSP) in anti- tumor responses. Curr Med Chem. 2012;19(12):1765–70.
CAS PubMed Article Google Scholar
Skitzki JJ, Repasky EA, Evans SS. Hyperthermia as an immunotherapy strategy for cancer. Curr Opin Investig Drugs. 2009;10(6):550–8.
CAS PubMed PubMed Central Google Scholar
Werthmöller N, et al. Combination of ionising radiation with hyperthermia increases the immunogenic potential of B16–F10 melanoma cells in vitro and in vivo. Int J Hyperth. 2016;32(1):23–30.
Elliott MR, et al. Nucleotides released by apoptotic cells act as a find-me signal to promote phagocytic clearance. Nature. 2009;461(7261):282–6.
CAS PubMed PubMed Central Article Google Scholar
Formenti SC, Demaria S. Combining radiotherapy and cancer immunotherapy: a paradigm shift. J Natl Cancer Inst. 2013;105(4):256–65.
CAS PubMed PubMed Central Article Google Scholar
Reits EA, et al. Radiation modulates the peptide repertoire, enhances MHC class I expression, and induces successful antitumor immunotherapy. J Exp Med. 2006;203(5):1259–71.
CAS PubMed PubMed Central Article Google Scholar
Kaur P, Asea A. Radiation-induced effects and the immune system in cancer. Front Oncol. 2012;2:191.
CAS PubMed PubMed Central Article Google Scholar
Carvalho HA, Villar RC. Radiotherapy and immune response: the systemic effects of a local treatment. Clinics (Sao Paulo). 2018;73(suppl 1):e557s.
Voll RE, et al. Immunosuppressive effects of apoptotic cells. Nature. 1997;390(6658):350–1.
Comments (0)